Nrf2-expressing DNA nanoparticles (Oklahoma Medical Research Foundation)

N/A

Report date: 2025/03/20 10:01:40
NME

Base Information

Drug NameNrf2-expressing DNA nanoparticles (Oklahoma Medical Research Foundation)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsOptic Neuritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOklahoma Medical Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesOklahoma Medical Research Foundation
Inactive CompaniesN/A
Active IndicationsOptic Neuritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A